Barclays PLC Has $503,000 Stock Position in Absci Co. (NASDAQ:ABSI)

Barclays PLC raised its holdings in Absci Co. (NASDAQ:ABSI) by 379.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 131,504 shares of the company’s stock after purchasing an additional 104,083 shares during the quarter. Barclays PLC owned 0.11% of Absci worth $503,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new stake in Absci in the third quarter valued at about $53,000. Farther Finance Advisors LLC lifted its holdings in shares of Absci by 119.5% in the third quarter. Farther Finance Advisors LLC now owns 18,876 shares of the company’s stock worth $72,000 after acquiring an additional 10,275 shares during the last quarter. Intech Investment Management LLC acquired a new stake in shares of Absci in the 3rd quarter valued at approximately $86,000. The Manufacturers Life Insurance Company bought a new stake in shares of Absci during the 2nd quarter valued at approximately $100,000. Finally, Cherry Creek Investment Advisors Inc. acquired a new position in Absci during the 3rd quarter worth approximately $149,000. Institutional investors own 52.05% of the company’s stock.

Wall Street Analyst Weigh In

ABSI has been the subject of several research reports. Guggenheim reissued a “buy” rating and issued a $10.00 price objective on shares of Absci in a research note on Tuesday, December 3rd. HC Wainwright reiterated a “buy” rating and issued a $7.00 price target on shares of Absci in a research note on Friday. Finally, KeyCorp cut their price objective on Absci from $6.00 to $5.00 and set an “overweight” rating on the stock in a report on Wednesday, January 8th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Absci has a consensus rating of “Buy” and a consensus target price of $8.50.

Absci Trading Up 3.6 %

ABSI opened at $2.90 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.63 and a quick ratio of 5.63. Absci Co. has a fifty-two week low of $2.45 and a fifty-two week high of $6.72. The company’s 50 day moving average price is $3.09 and its two-hundred day moving average price is $3.67. The firm has a market capitalization of $333.09 million, a price-to-earnings ratio of -3.12 and a beta of 2.04.

Absci (NASDAQ:ABSI) last issued its quarterly earnings data on Tuesday, November 12th. The company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.19) by ($0.05). The business had revenue of $1.70 million during the quarter, compared to the consensus estimate of $1.77 million. Absci had a negative return on equity of 46.56% and a negative net margin of 2,321.56%. During the same period in the prior year, the firm earned ($0.24) EPS. As a group, research analysts predict that Absci Co. will post -0.9 earnings per share for the current year.

About Absci

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit.